Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ARTH | US
0
0%
Healthcare
Biotechnology
30/06/2024
21/10/2024
0.30
0.30
0.30
0.30
Arch Therapeutics Inc. together with its subsidiaries operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking as well as manages wounds during surgery trauma and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat which are intended for skin applications such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham Massachusetts.
View LessStrong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
477.5%1 month
402.3%3 months
272.6%6 months
228.5%-
0.08
34.61
-
-
-3.44
70.96
-
-4.72M
1.33M
1.33M
-
-3.30K
-
132.60
-4.01K
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.29
Range1M
0.44
Range3M
0.78
Rel. volume
0.00
Price X volume
2.40
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
CohBar Inc | CWBR | Biotechnology | 0.5 | 1.45M | 0.00% | n/a | 0.00% |
TC BioPharm (Holdings) plc American Depositary Shares | TCBP | Biotechnology | 2.27 | 1.30M | -55.14% | n/a | 131.42% |
Evofem Biosciences Inc | EVFM | Biotechnology | 0.0092 | 923.03K | -8.00% | 0.00 | 0.00% |
Seelos Therapeutics Inc | SEEL | Biotechnology | 1.13 | 832.04K | 11.88% | 0.00 | -36.10% |
International Stem Cell Corporation | ISCO | Biotechnology | 0.06 | 480.26K | 0.00% | n/a | 0.00% |
NexImmune Inc. Common Stock | NEXI | Biotechnology | 0.2514 | 350.62K | -23.82% | n/a | 0.00% |
Vaxxinity Inc. Class A Common Stock | VAXX | Biotechnology | 0.002 | 253.57K | 0.00% | n/a | 113.12% |
Navidea Biopharmaceuticals Inc | NAVB | Biotechnology | 0.001 | 100.08K | 0.00% | n/a | -38.49% |
U.S. Stem Cell Inc | USRM | Biotechnology | 0.0001 | 64.15K | 0.00% | n/a | -60.68% |
EFTR | EFTR | Biotechnology | 0.0012 | 5.64K | 0.00% | n/a | 2315.36% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.44 | 0.53 | Cheaper |
Ent. to Revenue | 70.96 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 34.61 | 15.55 | Expensive |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 272.64 | 72.80 | Riskier |
Debt to Equity | - | -1.23 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 1.33M | 3.66B | Emerging |